| WKN: | A0JJT3 |
| ISIN: | US9216591084 |
| Land: | USA |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Pharma |
Weshalb die Vanda Pharmaceuticals-Aktie
ein C-Rating hat,
erfahren Sie im Performance-Check
vom 10. März 2026 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2013 | 2,40 | 8,89 | 270,42% |
| 2 | 2018 | 12,60 | 22,19 | 76,11% |
| 3 | 2016 | 8,75 | 15,03 | 71,77% |
| 4 | 2025 | 4,54 | 6,25 | 37,67% |
| 5 | 2021 | 10,50 | 14,40 | 37,14% |
| 6 | 2014 | 8,89 | 12,06 | 35,66% |
| 7 | 2024 | 3,70 | 4,54 | 22,70% |
| 8 | 2026 | 6,25 | 6,70 | 7,20% |
| 9 | 2010 | 8,19 | 7,04 | -14,04% |
| 10 | 2017 | 15,03 | 12,60 | -16,17% |
| 11 | 2015 | 12,06 | 8,75 | -27,45% |
| 12 | 2020 | 14,90 | 10,50 | -29,53% |
| 13 | 2012 | 3,42 | 2,40 | -29,82% |
| 14 | 2019 | 22,19 | 14,90 | -32,85% |
| 15 | 2023 | 6,75 | 3,70 | -45,19% |
| 16 | 2011 | 7,04 | 3,42 | -51,42% |
| 17 | 2022 | 14,40 | 6,75 | -53,13% |
| 18 | 2007 | 18,70 | 4,47 | -76,10% |
| 19 | 2008 | 4,47 | 0,36 | -91,95% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2008 | 4,47 | 0,36 | -91,95% |
| 2 | 2007 | 18,70 | 4,47 | -76,10% |
| 3 | 2022 | 14,40 | 6,75 | -53,13% |
| 4 | 2011 | 7,04 | 3,42 | -51,42% |
| 5 | 2023 | 6,75 | 3,70 | -45,19% |
| 6 | 2019 | 22,19 | 14,90 | -32,85% |
| 7 | 2012 | 3,42 | 2,40 | -29,82% |
| 8 | 2020 | 14,90 | 10,50 | -29,53% |
| 9 | 2015 | 12,06 | 8,75 | -27,45% |
| 10 | 2017 | 15,03 | 12,60 | -16,17% |
| 11 | 2010 | 8,19 | 7,04 | -14,04% |
| 12 | 2026 | 6,25 | 6,70 | 7,20% |
| 13 | 2024 | 3,70 | 4,54 | 22,70% |
| 14 | 2014 | 8,89 | 12,06 | 35,66% |
| 15 | 2021 | 10,50 | 14,40 | 37,14% |
| 16 | 2025 | 4,54 | 6,25 | 37,67% |
| 17 | 2016 | 8,75 | 15,03 | 71,77% |
| 18 | 2018 | 12,60 | 22,19 | 76,11% |
| 19 | 2013 | 2,40 | 8,89 | 270,42% |